Marc Carrier/X
Aug 18, 2025, 23:53
Radiotherapy and VTE Risk: Insights from Marc Carrier and Colleagues
Marc Carrier, Professor at Ottawa Hospital Research Institute, recently has shared a post on X:
“Radiotherapy is essential in cancer care, but evidence shows it may independently raise the risk of VTE.
This review in RPTH journal highlights mechanisms, diagnostic challenges, and why tailored thromboprophylaxis, not blanket use, is needed.”
Read the full article here.
Title: Radiotherapy—the not-so-insignificant contributor to cancer-associated venous thrombosis
Authors: Gerard Gurumurthy, Jacob Miller, Marc Carrier, Alok Khorana, Jecko Thachil
Stay informed on all science in Hematology with Hemostasis Today.
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia